Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... based cohort study using a new-user active comparator design. From 1 January 1990 to 30 April ...
The FDA has actually been fairly cautious about which PDL-1 checkpoint inhibitors it okays. It expressed that it was wary of the broad use of these drugs to treat stomach and esophageal cancers. This ...
Experts say the kuranui, otherwise known as moa, played a vital part in sustaining rākau Māori, crucial to the wellbeing of the taiao and the Māori language. The kuranui, otherwise known as moa ...
A SEVENTEEN pop-up store has officiall opened at the Mall of Asia on Wednesday. But it's not just any SEVENTEEN pop-up store, it's an “Artist-Made Collection by SEVENTEEN” pop-up store. Located at the ...
GLP-1 inhibitors such as semaglutide and tirzepatide have become popular and effective for weight loss and blood sugar control. However, they’re not without side effects. Keep in mind the following to ...
BJMP-10 has been actively collaborating with stakeholders to uphold its mission of humane safekeeping and PDL development, aligning with its vision of a modern and credible jail management system. As ...
The aim of this report is to present the results of conversion therapy with Gemcitabine plus S-1 (GS) combined with PD-1 inhibitors (Zimberelimab) in a 74-year-old female IIIB iCCA patient. After 6 ...
No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...
KRASG12C mutations are common and targetable alterations. Therapeutic inhibition of KRASG12C and eventual resistance to these inhibitors are also known to drive RS and DNA damage through adaptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback